SCHEMBL1819574

SCHEMBL1819574

Cc1ccc(S(=O)(=O)N2CCOc3ccc(-c4ccc(C#N)nc4)cc32)s1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.41
▸ MEN1 O00255 4/20 0.41
▸ PDE3B Q13370 4/20 0.39
▸ PDE3A Q14432 4/20 0.39
▸ MAPT P10636 3/20 0.38
▸ PIK3CD O00329 2/20 0.38
▸ PIK3CA P42336 2/20 0.38
▸ PIK3CB P42338 2/20 0.38
▸ PIK3CG P48736 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ KCNH2 Q12809 2/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ RIPK2 O43353 1/20 0.35
▸ NOD2 Q9HC29 1/20 0.35
▸ MTOR P42345 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1815394 0.89 PDE3B (0.40) KMT2AMEN1PDE3BPDE3AMAPT
SCHEMBL1818294 0.86 KMT2A (0.39) KMT2AMEN1PDE3BPDE3AMAPT
SCHEMBL1817728 0.85 KMT2A (0.41) KMT2AMEN1PDE3BPDE3AMAPT
SCHEMBL1818795 0.84 KMT2A (0.40) KMT2AMEN1PDE3BPDE3AMAPT
SCHEMBL1818915 0.84 KMT2A (0.43) KMT2AMEN1PDE3BPDE3AMAPT
SCHEMBL1819619 0.84 CYP2C9 (0.52) KMT2AMEN1PDE3BPDE3AMAPT
SCHEMBL1819521 0.83 MEN1 (0.40) KMT2AMEN1PDE3BPDE3AMAPT
SCHEMBL1818415 0.82 KMT2A (0.39) KMT2AMEN1PDE3BPDE3AMAPT
SCHEMBL1821031 0.81 KMT2A (0.41) KMT2AMEN1PDE3BPDE3AMAPT
SCHEMBL1818993 0.81 KMT2A (0.40) KMT2AMEN1PDE3BPDE3AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO claimed
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO disclosed
Send feedback